Antibodies to the N-Terminal Domain of Angiotensin-Converting Enzyme (ACE2) That Block Its Interaction with SARS-CoV-2 S Protein

被引：0
|
作者：
V. G. Krut
I. V. Astrakhantseva
S. A. Chuvpilo
G. A. Efimov
S. G. Ambaryan
M. S. Drutskaya
S. A. Nedospasov
机构：
[1] Sirius University of Science and Technology,
[2] National Medical Research Center of Hematology,undefined
[3] Ministry of Health of the Russian Federation,undefined
[4] Engelhardt Institute of Molecular Biology,undefined
[5] Russian Academy of Sciences,undefined
来源：
Doklady Biochemistry and Biophysics | 2022年 / 502卷
关键词：
COVID-19; peplomers; peptides; receptor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 4
页数：3
相关论文
共 50 条
  • [1] Antibodies to the N-Terminal Domain of Angiotensin-Converting Enzyme (ACE2) That Block Its Interaction with SARS-CoV-2 S Protein
    Krut, V. G.
    Astrakhantseva, I. V.
    Chuvpilo, S. A.
    Efimov, G. A.
    Ambaryan, S. G.
    Drutskaya, M. S.
    Nedospasov, S. A.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2022, 502 (01) : 1 - 4
  • [2] Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
    Bian, Jingwei
    Li, Zijian
    ACTA PHARMACEUTICA SINICA B, 2021, 11 (01) : 1 - 12
  • [3] ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases Ramifications for the Control of SARS-CoV-2
    Sharma, Ravindra K.
    Stevens, Bruce R.
    Obukhov, Alexander G.
    Grant, Maria B.
    Oudit, Gavin Y.
    Li, Qiuhong
    Richards, Elaine M.
    Pepine, Carl J.
    Raizada, Mohan K.
    HYPERTENSION, 2020, 76 (03) : 651 - 661
  • [4] Design of Inhibitory Peptides of the Interaction between the RBD Domain of the S1 Protein of SARS-CoV-2 and the Angiotensin-Converting Enzyme 2 (ACE2) Receptor
    Andres Rodriguez-Salazar, Carlos
    Piedad Recalde-Reyes, Delia
    Carlos Castano-Osorio, Jhon
    LETTERS IN DRUG DESIGN & DISCOVERY, 2021, 18 (07) : 666 - 673
  • [5] Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting
    Sharifkashani, Sourena
    Bafrani, Melika Arab
    Khaboushan, Alireza Soltani
    Pirzadeh, Marzieh
    Kheirandish, Ali
    Bali, Hanie Yavarpour
    Hessami, Amirhossein
    Saghazadeh, Amene
    Rezaei, Nima
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 884
  • [6] Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2)
    Xiang, Yusen
    Wang, Mengge
    Chen, Hongzhuan
    Chen, Lili
    BIOCHEMICAL PHARMACOLOGY, 2021, 192
  • [7] Screened Fv-Antibodies against the Angiotensin-Converting Enzyme 2 (ACE2) Receptor Neutralizing the Infection of SARS-CoV-2
    Jung, Jaeyong
    Kwon, Soonil
    Sung, Jeong Soo
    Bae, Hyung Eun
    Kang, Min-Jung
    Jose, Joachim
    Lee, Misu
    Pyun, Jae-Chul
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024, 7 (12) : 3914 - 3920
  • [8] In-silico Analysis of Angiotensin-converting Enzyme 2 (ACE2) of Livestock, Pet and Poultry Animals to Determine its Susceptibility to SARS-CoV-2 Infection
    Kumar, Aman
    Panwar, Anil
    Batra, Kanisht
    De, Sachinandan
    Maan, Sushila
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2021, 24 (10) : 1769 - 1783
  • [9] COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
    Beyerstedt, Stephany
    Casaro, Expedito Barbosa
    Rangel, Erika Bevilaqua
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (05) : 905 - 919
  • [10] COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
    Stephany Beyerstedt
    Expedito Barbosa Casaro
    Érika Bevilaqua Rangel
    European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 905 - 919
12345